FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Draft Guide on OTC Drug Minor Changes

FDA posts a draft guidance entitled Recommendations for Complying With Over-the-Counter Monograph Procedure for Minor Changes C001: Minor Changes to S...

latest-news-card-1
Human Drugs

Evi Labs CGMP Violations

FDA warns Medley, FL-based Evi Labs about CGMP violations in its work as a contract drug manufacturer.

latest-news-card-1
Medical Devices

Guide on 510(k) Transfers/Sales

FDA publishes a draft guidance entitled Transfer of a Premarket Notification (510(k)) Clearance Questions and Answers.

latest-news-card-1
Medical Devices

Pandemic Diagnostic Testing Plan Needed: GAO

The Government Accountability Office says there are things HHS, FDA, and other units should do to help create a coordinated national approach for diag...

latest-news-card-1
Human Drugs

2 FDA Officials Part of Wrongful Termination Lawsuit

Two former FDA officials add their names to a class-action wrongful termination lawsuit alleging the federal government knowingly used flawed and inac...

latest-news-card-1
FDA General

Sources Question FDA Internal AI: NBC

Anonymous and named sources raise questions for NBC News about FDAs use of internal AI tools in product reviews and approvals.

Medical Devices

QS Issues at DFI Company

FDA warns Koreas DFI Co., Ltd. about Quality System and Medical Device Reporting violations in its manufacturing of reagent strips.

latest-news-card-1
FDA General

Pay Attention to FDA AI Reviews: Attorneys

Three Morgan Lewis attorneys tell regulated product sponsors to watch for AI involvement in FDA reviews and be prepared to respond when necessary.

latest-news-card-1
Human Drugs

NDA Filed for Kuras Ziftomenib for Rare Leukemia

FDA accepts for priority review a Kura Oncology NDA for ziftomenib, a potential new treatment for certain adult patients with relapsed or refractory a...

latest-news-card-1
Medical Devices

Clarity Breast Gets FDA De Novo Authorization

FDA gives de novo authorization to Clarity Breast which uses artificial intelligence to make a five-year breast cancer risk prediction from a screenin...